KRYSP-R LLC

KRYSP-R is a biotechnology company founded in 2021 that specializes in CRISPR-based genome engineering services. The firm provides a range of solutions, including the generation of gene knock-in and knock-out cell lines for mammalian research, genome editing in plant cell lines to improve agricultural yields, and the study of microorganisms to identify potential drug targets. Their technical offerings also include pre-validated CRISPR reagents and plasmids. Operating with facilities in both the United States and India, the company utilizes a state-of-the-art laboratory environment, including a strategic presence at the Centre for Cell and Molecular Platforms (C-CAMP) in Bangalore, to support scientific research and development.

These services are designed to assist researchers and pharmaceutical developers in solving complex genome engineering challenges by providing fast, accurate, and affordable tools. By offering tailor-made, client-specific genome editing solutions, KRYSP-R aims to make advanced CRISPR technology more accessible to laboratories globally. The company serves the biotechnology, pharmaceutical, and healthcare sectors, addressing critical needs in disease modeling, therapeutic research, and agricultural innovation. Their approach leverages deep expertise in genetics to help partners navigate scientific bottlenecks, improve research productivity, and accelerate the development of new treatments and products."},field_source_urls:[{field: